Thank you to everyone who made it out to our annual holiday party. Take a look at the gallery below for some of the highlights of the evening.
For the upcoming holidays, we will be closed Monday, December 26, and Monday, January 2. We wish you a healthy and happy holiday season!
The production facility is a cGMP/FDA registered PET drug manufacturer that consists of an ISO Class 8 manufacturing area, an ISO Class 7 cleanroom and a quality control lab. The core laboratories are equipped with over 20 mini cells and automated chemistry modules used primarily for the synthesis of 18F, 11C and 13N radiopharmaceuticals.Click on video for more
We are pleased to announce Dr. Quanzheng Li's promotion to Associate Professor at Harvard Medical School. Dr. Li received his doctoral degree in Electrical Engineering in 2005 from the University of Southern California before joining Masschusetts General Hospital in 2011. He has published several works on image reconstruction and kinetic modeling, and is the recipient of several honors including the IEEE-NPSS Early Achievement Award.
Researchers at the Gordon Center for Medical Imaging are using molecular imaging and nuclear medicine technology to push the boundaries of personalized medicine. We talked to Dr. Rachid Akiki, MD, who is working closely with Dr. Marc Normandin, PhD, in the Gordon Center of the Radiology Department, to find out how.
What is molecular imaging?
Molecular imaging provides detailed pictures of what’s happening inside the body at the smallest level, cells and molecules. Using tracers to illuminate cellular activity, molecular imaging can reveal how a cell behaves and help us understand disease progression. Molecular imaging can confirm a diagnosis, monitor and assess the effectiveness of a treatment like chemotherapy. It is the basis upon which pharmacological companies create new drugs.
How does molecular imaging help you research disease?
We commonly use MRI, CT and PET to take a closer look at the behavior of cells affected by diseases such as cancer, diabetes, heart and kidney problems. Using a small amount of PET tracer, molecular imaging can help improve the ways we diagnose and treat a disease on a case-by-case basis. Cancer cells, for instance, can form unique structures and behave differently from patient to patient.
Our new microscope is unique in that it can be used to do single cell PET instead of whole body imaging. This scaled down modality (10s of microns) allows to better understand what we typically image at the whole body, 1cm scale, and possibly assess how cells respond to treatment and compare their behaviors with normal cells under different circumstances. Innovations like these, combined with data on cellular activity, are the foundation of personalized medicine.
Tell us about a recent project?
Tell us about yourself?I am 26 years old and have studied physics at AUB, medicine and medical imaging at BU. Currently I work as a postdoctoral research fellow at Massachusetts General Hospital with an appointment at Harvard medical school on nuclear medicine research topics and their applications in medicine. I like very much my research work and I hope I can affect positively the lives of people significantly while advancing the science. I look forward to start my clinical residency in 2016 and translate my research work to the clinical setting.
The following study is currently looking for participants.
Quantitative Neurological PET/CT Imaging
We are looking for healthy volunteers who are at least 18 years of age. Participation involves answering brief questions about medical and family history, and having a PET/CT scan.
Participation may also involve having arterial blood sampling.
Procedures will take a total of about three hours on one visit day. Participants will be paid for their time and effort upon completion.
Participation is confidential.
For more information, please call Julia-Ann Scotton at 617-643-1967, Monday through Friday, 9:00am-5:00pm.
The Gordon Center for Medical Imaging in the Department of Radiology at Massachusetts General Hospital (MGH) and Harvard Medical School (HMS) in Boston, Massachusetts has an opening for qualified individuals at the post-doctoral level to work on research related to quantitative Single Photon Emission Computed Tomography (SPECT) and simultaneous Positron Emission Tomography and Magnetic Resonance (PET-MR). The Department of Radiology at MGH is equipped with the first mobile PET/CT, the first brain PET/MRI, and the first whole-body PET/MRI in the USA. It is also equipped with SPECT/CT, and a substantial large scale shared memory computing facility for computationally intensive research applications.Read more...
Georges El Fakhri, of the Department of Radiology and the Gordon Center, and Thomas Bortfeld, of the Department of Radiation Oncology, are pleased to announce the establishment of the Therapy Imaging Program (TIP) at MGH. TIP is supported by Federal Share of program income earned by MGH on C06 CA059267.
The mission of TIP:
- To achieve the best proton therapy treatment through advanced imaging.
- To support NCI proton therapy clinical trials at MGH and elsewhere using imaging as a biomarker
More information can be found on the TIP page